# EDGAR Filing Document

**Accession Number:** 0001687880
**File Stem:** 0001193125-23-030078
**Filing Date:** 2023-2
**Character Count:** 21960
**Document Hash:** 5f2d09eba73e446a946da318299e4511
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-030078.hdr.sgml**: 20230209

**ACCESSION NUMBER**: 0001193125-23-030078

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230209

**DATE AS OF CHANGE**: 20230209

**GROUP MEMBERS**: VERSANT VANTAGE II GP, L.P.

**GROUP MEMBERS**: VERSANT VANTAGE II GP-GP, LLC

**GROUP MEMBERS**: VERSANT VANTAGE II, L.P.

**GROUP MEMBERS**: VERSANT VENTURES VI GP, L.P.

**GROUP MEMBERS**: VERSANT VENTURES VI GP-GP, LLC

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Century Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001850119
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 842040295
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92725
- **FILM NUMBER:** 23606495

**BUSINESS ADDRESS:**
- **STREET 1:** 3675 MARKET STREET
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19104
- **BUSINESS PHONE:** 215-981-4000

**MAIL ADDRESS:**
- **STREET 1:** 3675 MARKET STREET
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19104
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Versant Venture Capital VI, L.P.
- **CENTRAL INDEX KEY:** 0001687880
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** ONE SANSOME STREET, SUITE 3630
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94104
- **BUSINESS PHONE:** (415) 801-8100

**MAIL ADDRESS:**
- **STREET 1:** ONE SANSOME STREET, SUITE 3630
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94104

------

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**SCHEDULE 13G** 

**(Rule 13d-102)**

**INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO** 

**RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO** 

**13d-2 (b)** 

**(Amendment No. 1)** 

------

## Century Therapeutics, Inc.
**(Name of Issuer)** 

**Common Stock, par value $0.0001 per share** 

**(Title of Class of Securities)** 

**15673T100** 

**(CUSIP Number)** 

**December 31, 2022** 

**(Date of Event Which Requires Filing of this Statement)** 

------

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

------

CUSIP No. 15673T100 13G

1. &nbsp;&nbsp;&nbsp;&nbsp; Name of Reporting Persons &nbsp;&nbsp;&nbsp;&nbsp; Versant Venture Capital VI, L.P.

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☒(1)

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;11,452,014 shares of Common Stock (2) |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;11,452,014 shares of Common Stock (2) |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 11,452,014 shares of Common Stock (2)

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row 9 Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of Class
Represented by Amount in Row 9 &nbsp;&nbsp;&nbsp;&nbsp; 19.4% (3)

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; PN

(1) This Schedule 13G is filed by Versant Venture Capital VI, L.P. ("Versant VI"), Versant Ventures VI
GP, L.P. ("Versant VI GP LP"), Versant Ventures VI GP-GP, LLC ("Versant VI GP LLC"), Versant Vantage II, L.P. ("Vantage II"), Versant Vantage II GP, L.P. ("Vantage II GP
LP") and Versant Vantage II GP-GP, LLC ("Vantage II GP LLC" and together with Vantage II, Vantage II GP LP, Versant VI, Versant VI GP LP and Versant VI GP LLC, the "Reporting
Persons"). Versant VI GP LP is the sole general partner of Versant VI and Versant VI GP LLC is the sole general partner of Versant VI GP LP, each of which may be deemed to have voting, investment and dispositive power over the securities held
by Versant VI. Vantage II GP LP is the sole general partner of Vantage II and Vantage II GP LLC is the sole general partner of Vantage II GP LP, each of which may be deemed to have voting, investment and dispositive power over the securities held by
Vantage II. The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.

(2) These shares are held by Versant VI. Versant VI GP LLC is the sole general partner of Versant VI GP LP, which
is the sole general partner of Versant VI. Each of Versant VI GP LLC and Versant VI GP LP share voting, investment and dispositive power over the securities held by Versant VI and as a result may be deemed to have beneficial ownership over such
securities.

(3) This calculation is based upon 58,974,247 shares of the Issuer's Common Stock outstanding as of
November 4, 2022, as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2022, filed with the United States Securities and Exchange Commission (the
"Commission") on November 10, 2022 (the "Form 10-Q").

------

CUSIP No. 15673T100 13G

1. &nbsp;&nbsp;&nbsp;&nbsp; Name of Reporting Persons &nbsp;&nbsp;&nbsp;&nbsp; Versant Ventures VI GP, L.P.

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☒(1)

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;11,452,014 shares of Common Stock (2) |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;11,452,014 shares of Common Stock (2) |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 11,452,014 shares of Common Stock (2)

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row 9 Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of Class
Represented by Amount in Row 9 &nbsp;&nbsp;&nbsp;&nbsp; 19.4% (3)

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; PN

(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a
"group" for purposes of this Schedule 13G.

(2) These shares are held by Versant VI. Versant VI GP LLC is the sole general partner of Versant VI GP LP, which
is the sole general partner of Versant VI. Each of Versant VI GP LLC and Versant VI GP LP share voting, investment, and dispositive power over the securities held by Versant VI and as a result may be deemed to have beneficial ownership over such
securities.

(3) This calculation is based upon 58,974,247 shares of the Issuer's Common Stock outstanding as of
November 4, 2022, as set forth in the Form 10-Q.

------

CUSIP No. 15673T100 13G

1. &nbsp;&nbsp;&nbsp;&nbsp; Name of Reporting Persons &nbsp;&nbsp;&nbsp;&nbsp; Versant Ventures VI GP-GP, LLC

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☒(1)

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;11,452,014 shares of Common Stock (2) |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;11,452,014 shares of Common Stock (2) |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 11,452,014 shares of Common Stock (2)

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row 9 Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of Class
Represented by Amount in Row 9 &nbsp;&nbsp;&nbsp;&nbsp; 19.4% (3)

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; OO

(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a
"group" for purposes of this Schedule 13G.

(2) These shares are held by Versant VI. Versant VI GP LLC is the sole general partner of Versant VI GP LP, which
is the sole general partner of Versant VI. Each of Versant VI GP LLC and Versant VI GP LP share voting, investment and dispositive power over the securities held by Versant VI and as a result may be deemed to have beneficial ownership over such
securities.

(3) This calculation is based upon 58,974,247 shares of the Issuer's Common Stock outstanding as of
November 4, 2022, as set forth in the Form 10-Q.

------

CUSIP No. 15673T100 13G

1. &nbsp;&nbsp;&nbsp;&nbsp; Name of Reporting Persons &nbsp;&nbsp;&nbsp;&nbsp; Versant Vantage II, L.P.

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☒(1)

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;714,095 shares of Common Stock (2) |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;714,095 shares of Common Stock (2) |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 714,095 shares of Common Stock (2)

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row 9 Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of Class
Represented by Amount in Row 9 &nbsp;&nbsp;&nbsp;&nbsp; 1.2% (3)

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; PN

(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a
"group" for purposes of this Schedule 13G.

(2) These shares are held by Vantage II. Vantage II GP LLC is the sole general partner of Vantage II GP LP, which
is the sole general partner of Vantage II. Each of Vantage II GP LLC and Vantage II GP LP share voting, investment and dispositive power over the securities held by Vantage II and as a result may be deemed to have beneficial ownership over such
securities.

(3) This calculation is based upon 58,974,247 shares of the Issuer's Common Stock outstanding as of
November 4, 2022, as set forth in the Form 10-Q.

------

CUSIP No. 15673T100 13G

1. &nbsp;&nbsp;&nbsp;&nbsp; Name of Reporting Persons &nbsp;&nbsp;&nbsp;&nbsp; Versant Vantage II GP, L.P.

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☒(1)

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;714,095 shares of Common Stock (2) |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;714,095 shares of Common Stock (2) |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 714,095 shares of Common Stock (2)

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row 9 Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of Class
Represented by Amount in Row 9 &nbsp;&nbsp;&nbsp;&nbsp; 1.2% (3)

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; PN

(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a
"group" for purposes of this Schedule 13G.

(2) These shares are held by Vantage II. Vantage II GP LLC is the sole general partner of Vantage II GP LP, which
is the sole general partner of Vantage II. Each of Vantage II GP LLC and Vantage II GP LP share voting, investment and dispositive power over the securities held by Vantage II and as a result may be deemed to have beneficial ownership over such
securities.

(3) This calculation is based upon 58,974,247 shares of the Issuer's Common Stock outstanding as of
November 4, 2022, as set forth in the Form 10-Q.

------

CUSIP No. 15673T100 13G

1. &nbsp;&nbsp;&nbsp;&nbsp; Name of Reporting Persons &nbsp;&nbsp;&nbsp;&nbsp; Versant Vantage II GP-GP, LLC

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☒(1)

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;714,095 shares of Common Stock (2) |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;714,095 shares of Common Stock (2) |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 714,095 shares of Common Stock (2)

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row 9 Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of Class
Represented by Amount in Row 9 &nbsp;&nbsp;&nbsp;&nbsp; 1.2% (3)

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; OO

(1) This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a
"group" for purposes of this Schedule 13G.

(2) These shares are held by Vantage II. Vantage II GP LLC is the sole general partner of Vantage II GP LP, which
is the sole general partner of Vantage II. Each of Vantage II GP LLC and Vantage II GP LP share voting and investment power over the securities held by Vantage II and as a result may be deemed to have beneficial ownership over such securities.

(3) This calculation is based upon 58,974,247 shares of the Issuer's Common Stock outstanding as of
November 4, 2022, as set forth in the Form 10-Q.

------

**Introductory Note**: This Amendment No. 1 (the "Amendment") amends and supplements the Schedule 13G originally filed by the Reporting Persons with the Commission on February 11, 2022 (the "Original Schedule 13G"). Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13G remain unchanged. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Amendment have the meanings ascribed to them in the Original Schedule 13G.

---

| | |
|:---|:---|
| **Item 4** | **Ownership.**  |

---

(a) Amount beneficially owned:

See Row 9 of the cover page for each Reporting Person.\*

(b) Percent of class:

See Row 11 of the cover page for each Reporting Person.\*

(c) Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote

See Row 5 of the cover page for each Reporting Person.\*

(ii) Shared power to vote or to direct the vote

See Row 6 of the cover page for each Reporting Person.\*

(iii) Sole power to dispose or to direct the disposition of

See Row 7 of the cover page for each Reporting Person.\*

(iv) Shared power to dispose or to direct the disposition of

See Row 8 of the cover page for each Reporting Person.\*

\* Each of the Reporting Persons disclaims beneficial ownership as to such securities, except to the extent of his, her or its pecuniary interest therein.

------

**SIGNATURE** 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 9, 2023

---

| | |
|:---|:---|
| **Versant Venture Capital VI, L.P.** | **Versant Venture Capital VI, L.P.** |
| By: | Versant Ventures VI GP, L.P. |
| Its: | General Partner |
| By: | Versant Ventures VI GP-GP, LLC |
| Its: | General Partner |
| By: | /s/ Max Eisenberg |
|  | Max Eisenberg, Chief Operating Officer |
| **Versant Ventures VI GP, L.P.** | **Versant Ventures VI GP, L.P.** |
| By: | Versant Ventures VI GP-GP, LLC |
| Its: | General Partner |
| By: | /s/ Max Eisenberg |
|  | Max Eisenberg, Chief Operating Officer |
| **Versant Ventures VI GP-GP, LLC** | **Versant Ventures VI GP-GP, LLC** |
| By: | /s/ Max Eisenberg |
|  | Max Eisenberg, Chief Operating Officer |
| **Versant Vantage II, L.P.** | **Versant Vantage II, L.P.** |
| By: | Versant Vantage II GP, L.P. |
| Its: | General Partner |
| By: | Versant Vantage II GP-GP, LLC |
| Its: | General Partner |
| By: | /s/ Max Eisenberg |
|  | Max Eisenberg, Chief Operating Officer |
| **Versant Vantage II GP, L.P.** | **Versant Vantage II GP, L.P.** |
| By: | Versant Vantage II GP-GP, LLC |
| Its: | General Partner |
| By: | /s/ Max Eisenberg |
|  | Max Eisenberg, Chief Operating Officer |
| **Versant Vantage II GP-GP, LLC** | **Versant Vantage II GP-GP, LLC** |
| By: | /s/ Max Eisenberg |
|  | Max Eisenberg, Chief Operating Officer |

---